Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Gliosarcoma 11Glioblastoma 11Prostatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Brain Neoplasms 4Astrocytoma 4Adenocarcinoma of Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pinealoma 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malignant mesenchymal tumor 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Glioma 2Fibrosarcoma 2Ependymoma 2

Interventions

tocotrienol, delta 1dehydroftorafur 1X-Rays 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Fluorouracil 1Ethanol 1Erlotinib Hydrochloride 1Drug Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Intraductal Neoplasms × Radiotherapy, Conformal × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡